Brii Ups Its Bet On VBI’s Hepatitis B Assets Amid Larger Treatment, Prevention Push

 
• By Alaric DeArment

The two companies have partnered on VBI-2601 since 2018, and Brii is now taking global rights to that program as well as licensing rights to VBI’s hepatitis B vaccine.

Brii is in-licensing VBI's hepatitis B vaccine • Source: Shutterstock

More from Deals

More from Business